{"id":"https://openalex.org/W4386281981","doi":"https://doi.org/10.1016/s2152-2650(23)00527-x","title":"POSTER: CLL-542 High Rates of Undetectable Minimal Residual Disease Remissions With Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL) \u2014 an Updated Analysis","display_name":"POSTER: CLL-542 High Rates of Undetectable Minimal Residual Disease Remissions With Time-Limited Bendamustine, Rituximab, and Venetoclax (BR-VR) in Untreated Chronic Lymphocytic Leukemia (CLL) \u2014 an Updated Analysis","publication_year":2023,"publication_date":"2023-08-30","ids":{"openalex":"https://openalex.org/W4386281981","doi":"https://doi.org/10.1016/s2152-2650(23)00527-x"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(23)00527-x","doi":"https://doi.org/10.1016/s2152-2650(23)00527-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)00527-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064778715","display_name":"Andrew H. Lipsky","orcid":"https://orcid.org/0000-0002-7653-4792","observed_orcids":["https://orcid.org/0000-0002-7653-4792"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Lipsky","raw_affiliation_strings":["Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006235077","display_name":"Brian Thomas Hill","orcid":"https://orcid.org/0000-0001-8781-3327","observed_orcids":["https://orcid.org/0000-0001-8781-3327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Hill","raw_affiliation_strings":["Taussig Cancer Center Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Center Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009726852","display_name":"Allison Marie Winter","orcid":"https://orcid.org/0000-0002-8437-7539","observed_orcids":["https://orcid.org/0000-0002-8437-7539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison Winter","raw_affiliation_strings":["Taussig Cancer Center Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Center Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055703943","display_name":"Joseph Gerard Jurcic","orcid":"https://orcid.org/0000-0002-1671-9998","observed_orcids":["https://orcid.org/0000-0002-1671-9998"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Jurcic","raw_affiliation_strings":["Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044188379","display_name":"Todd Louis Rosenblat","orcid":"https://orcid.org/0000-0002-9769-4832","observed_orcids":["https://orcid.org/0000-0002-9769-4832"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd Rosenblat","raw_affiliation_strings":["Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010100538","display_name":"Nicole Lamanna","orcid":"https://orcid.org/0000-0003-3331-9491","observed_orcids":["https://orcid.org/0000-0003-3331-9491"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole Lamanna","raw_affiliation_strings":["Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3670,"currency":"USD","value_usd":3670},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.16643444,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":null,"first_page":"S173","last_page":"S173"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.843999981880188},{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":0.8840000033378601},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9330000281333923},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.9990000128746033},{"id":"https://openalex.org/keywords/time-limited-psychotherapy","display_name":"time-limited therapy","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9580439329147339},{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.9343580007553101},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7013677954673767},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.653835654258728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6477988958358765},{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.5584633946418762},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45148685574531555},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43098631501197815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3030819892883301},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.21517661213874817}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(23)00527-x","doi":"https://doi.org/10.1016/s2152-2650(23)00527-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(23)00527-x","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3213395006","https://openalex.org/W4386271108","https://openalex.org/W4389231070","https://openalex.org/W7204692623","https://openalex.org/W3095661021","https://openalex.org/W2910748507","https://openalex.org/W7029179474","https://openalex.org/W2981304043","https://openalex.org/W2991372896","https://openalex.org/W4281385697"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-08-31T00:00:00"}